Literature DB >> 11837327

Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging.

Michael R Hamblin1, David A O'Donnell, Naveen Murthy, Christopher H Contag, Tayyaba Hasan.   

Abstract

The worldwide rise in antibiotic resistance necessitates the development of novel antimicrobial strategies. In this study we report on the first use of a photochemical approach to destroy bacteria infecting a wound in an animal model. Following topical application, a targeted polycationic photosensitizer conjugate between poly-L-lysine and chlorin(e6) penetrated the gram (-) outer bacterial membrane, and subsequent activation with 660 nm laser light rapidly killed Escherichia coli infecting excisional wounds in mice. To facilitate real-time monitoring of infection, we used bacteria that expressed the lux operon from Photorhabdus luminescens; these cells emitted a bioluminescent signal that allowed the infection to be rapidly quantified, using a low-light imaging system. There was a light-dose dependent loss of luminescence in the wound treated with conjugate and light, not seen in untreated wounds. Treated wounds healed as well as control wounds, showing that the photodynamic treatment did not damage the host tissue. Our study points to the possible use of this methodology in the rapid control of wounds and other localized infections.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11837327     DOI: 10.1562/0031-8655(2002)075<0051:rcowib>2.0.co;2

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  85 in total

1.  Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects.

Authors:  Eleonora Reginato; Peter Wolf; Michael R Hamblin
Journal:  World J Immunol       Date:  2014-03-27

2.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

3.  Targeted photodynamic therapy of established soft-tissue infections in mice.

Authors:  Faten Gad; Touqir Zahra; Kevin P Francis; Tayyaba Hasan; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2004-02-11       Impact factor: 3.982

4.  Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria.

Authors:  Faten Gad; Touqir Zahra; Tayyaba Hasan; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 5.  Photodynamic therapy targeted to pathogens.

Authors:  T N Demidova; M R Hamblin
Journal:  Int J Immunopathol Pharmacol       Date:  2004 Sep-Dec       Impact factor: 3.219

Review 6.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 7.  Noninvasive biophotonic imaging for studies of infectious disease.

Authors:  Nuria Andreu; Andrea Zelmer; Siouxsie Wiles
Journal:  FEMS Microbiol Rev       Date:  2010-10-19       Impact factor: 16.408

8.  Potentiation of antimicrobial photodynamic inactivation mediated by a cationic fullerene by added iodide: in vitro and in vivo studies.

Authors:  Yunsong Zhang; Tianhong Dai; Min Wang; Daniela Vecchio; Long Y Chiang; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2015-03       Impact factor: 5.307

Review 9.  [Antibacterial photodynamic therapy. A new treatment for superficial bacterial infections?].

Authors:  T Maisch; R-M Szeimies; N Lehn; C Abels
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

10.  Antimicrobial photodynamic therapy combined with conventional endodontic treatment to eliminate root canal biofilm infection.

Authors:  Aguinaldo S Garcez; Martha S Ribeiro; George P Tegos; Silvia C Núñez; Antonio O C Jorge; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2007-01       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.